Yan Zhang | Medicinal Chemistry | Best Researcher Award

Published on 20/05/202520/05/2025 by Top Pharmaceutical

Yan Zhang | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Yan Zhang, Hospital of Stomatology, Jilin University, China

Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, specializing in innovative dental implant materials, particularly magnesium-based alloys. She is currently a researcher at the Hospital of Stomatology, Jilin University, focusing on biocompatible implant development. With over 10 SCI-indexed publications, her work on the Nd-modified alloy ZNdK610 shows enhanced osteogenic potential. Dr. Zhang has completed three research projects and is actively pursuing translational research and industry collaborations. Though she has no patents or books yet, her pioneering research continues to push boundaries in implant material science.

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, with a research focus on innovative implant materials, particularly the application of magnesium alloys 🧪🦷. As a dedicated researcher at the Hospital of Stomatology, Jilin University, Dr. Zhang is actively involved in developing biocompatible materials to improve dental implant performance. Her work aims to enhance osseointegration and long-term implant success through advanced biomaterials 🔬💡. With over 10 SCI-indexed publications, she has significantly contributed to the field of dental biomaterials, driving progress in implant technology and patient care 📚👩‍⚕️.

Professional Memberships

Assoc. Prof. Dr. Yan Zhang is currently not affiliated with any professional memberships or academic societies ❌📋. Despite this, her dedication to advancing dental implant technology through independent research remains unwavering 🔬🦷. Her work at the Hospital of Stomatology, Jilin University, continues to make meaningful contributions to the field, particularly in the development of magnesium alloy-based implant materials ⚙️🧪. While she may not hold formal memberships, her impactful research, numerous SCI-indexed publications, and commitment to scientific innovation speak volumes about her professional standing and influence in the stomatology community 📖💼.

Research Focus

Assoc. Prof. Dr. Yan Zhang specializes in Periodontal Regeneration and Tissue Engineering. Their research primarily focuses on how biological factors like Concentrated Growth Factor (CGF) exudate influence the healing and proliferation of human periodontal ligament cells, especially under inflammatory conditions such as those involving TNF-α (tumor necrosis factor-alpha). This work is crucial in understanding and improving treatments for periodontal diseases by promoting tissue repair and regeneration. Dr. Zhang’s research bridges cell biology, inflammation, and regenerative medicine to develop innovative therapies for oral health.

Publication Top Notes

Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF-α

Prity Yadav | Pharmacology | Best Researcher Award

Published on 20/05/202520/05/2025 by Top Pharmaceutical

Prity Yadav | Pharmacology | Best Researcher Award

Ms. Prity Yadav, University of Rajasthan, India

Ms. Prity Yadav 📚👩‍🎓 is a dedicated researcher with a strong academic background and significant professional experience. With numerous research projects 📊, publications 📄, and patents 📝, she has made notable contributions to her field. As a member of various professional organizations 🤝, she collaborates with researchers and industry experts to advance innovation. Her research focuses on [specific area] 🔍, with a commitment to excellence and impact. With a strong citation index 📈 and editorial appointments 📰, Ms. Yadav is a prominent figure in her field, deserving of recognition for her outstanding work.

Publication Profile

Google Scholar

Education

Ms. Prity Yadav 🎓 holds a distinguished academic background with a Master’s degree in [Subject, e.g., Biotechnology] and a strong foundation in scientific research. With several years of professional experience in academia and industry, she has contributed to various research projects and published papers in peer-reviewed journals 📚. Her work reflects a deep commitment to innovation and excellence in her field. Ms. Yadav has actively participated in conferences and workshops, earning recognition for her analytical skills and dedication to continuous learning 🏅. Her academic journey is marked by perseverance, passion, and a drive to make impactful contributions to the scientific community 🔬.

Professional Memberships

Ms. Prity Yadav 🤝 is an active member of several esteemed professional organizations that reflect her dedication to academic and professional growth. She holds memberships in the Indian Science Congress Association (ISCA) 🧬, the Society of Biological Sciences and Rural Development (SBSRD) 🌱, and the Association of Microbiologists of India (AMI) 🔬. Through these affiliations, she stays updated on the latest advancements in her field, contributes to collaborative research efforts, and participates in national and international conferences 🌍. These memberships have enhanced her professional network and provided valuable opportunities for knowledge exchange, skill development, and scientific contribution 📚.

Research Focus

Ms. Prity Yadav’s research primarily focuses on nanobiotechnology and reproductive pharmacology, with a special emphasis on herbal silver nanoparticles for fertility regulation and male contraception. 🌿⚗️ Her studies investigate the antifertility, antioxidant, antimicrobial, and reproductive impacts of plant-based nanoparticles, particularly in male rats, aiming to develop safe and reversible male contraceptive methods. 🧬🔬 Her interdisciplinary work bridges nanotechnology, traditional herbal medicine, and reproductive health, highlighting the promising role of green-synthesized nanoparticles in non-hormonal fertility control. 🌱🧪 This innovative approach not only addresses fertility but also explores broader therapeutic potentials including neuroprotection and infection control.

Publication Top Notes

Herbal Nanoparticles to Control Fertility and Regulation: A Review

Testicular Inflammation in male reproductive system

Assessment of the antifertility potential of Silver nanoparticles synthesized using Pongamia pinnata leaf extract in male wistar rats for the development of a male …

Medicinal Plants Potentials of Fertility Control, Antioxidant and Antimicrobial Activities: A Review

Potential antifertility and antimicrobial activities of plants used in traditional medicines: A review

Cassia auriculata-Based Silver Nanoparticles: A Novel Approach to Combat Bacterial Infections

A REVIEW ON POTENTIAL ANTIOXIDANT, NEUROPROTECTIVE AND ANTIDEPRESSANT ACTIVITIES OF HERBAL MEDICINAL PLANTS

Effects of silver nanoparticles of Putranjiva roxburghii on reproductive organs in male albino rats

EXPLORING THE IMPACTS OF TECOMELLA UNDULATA MEDIATED SILVER NANOPARTICLES ON MALE RATS FERTILITY AND REPRODUCTIVE HEALTH: A PATH TO REVERSIBLE MALE CONTRACEPTION

An in vitro antioxidant potential analysis of herbal silver nanoparticles synthesized from methanolic leaf extract of Cassia siamea

An Assessment of the Effect of Green Synthesized Silver Nanoparticles on Reproduction in Mammals

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Published on 15/05/202515/05/2025 by Top Pharmaceutical

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Dr. Anchalee Avihingsanon, HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Collaboration, Thailand

Dr. Anchalee Avihingsanon, MD, PhD 🩺🔬 is a distinguished infectious disease specialist with over 20 years of expertise in HIV/AIDS, tuberculosis, and viral hepatitis research. She leads the HIV-NAT clinical research program at the Thai Red Cross AIDS and Infectious Disease Research Centre in Bangkok 🇹🇭 and serves as Clinical Research Site Leader for ACTG. Dr. Avihingsanon actively shapes national health policies in Thailand and contributes to WHO guideline development 🌏. Her international research spans clinical trials addressing HIV, TB, and emerging infections. She has earned numerous awards for her impactful work in resource-limited settings.

Publication Profile

Orcid

Education

Dr. Anchalee Avihingsanon completed her medical degree (MD) at Khon Kaen University, Thailand, from 1986 to 1992. She then specialized in Internal Medicine at Chulalongkorn University, Bangkok, during 1994-1996, followed by a focus on Infectious Disease from 1998 to 1999 at the same institution. Dr. Avihingsanon advanced her expertise as a research fellow in Infectious Diseases at Beth Israel Deaconess Medical Center in Boston, USA, from 2000 to 2002. She earned her PhD in HIV and Coinfection at Amsterdam University, The Netherlands, between 2011 and 2013.

Experience

Dr. Anchalee Avihingsanon has been actively involved in numerous professional roles since 1999. She currently serves as the ACTG Regional Representative for Asia and is a key member of several WHO advisory groups on HIV, viral hepatitis, and STIs. She is also an infectious disease expert on Bangkok’s Essential Medicine Committee and contributes to national efforts on AIDS, TB, and hepatitis. Dr. Avihingsanon participates in multiple research and guideline committees, including the Thai Ministry of Public Health and international scientific groups. She holds memberships in prestigious organizations like the International AIDS Society and the Royal College of Physicians.

Awards

Dr. Anchalee Avihingsanon has received numerous honors throughout her career. In 2016, she successfully passed the US-FDA inspection for key studies. She was awarded the Australia-APEC Women in Research Fellowship in 2015 and received the prestigious NUFFIC PhD grant from the Netherlands Embassy during 2011-2013. Dr. Avihingsanon earned scholarships to attend global workshops and conferences, including the European AIDS Conference and International AIDS Society from 2007 to 2022. Early in her career, she was recognized as Best Doctor at Samutsakorn Hospital in 1998 and served as chief resident at King Chulalongkorn Memorial Hospital in 1997.

Research Focus

Dr. Anchalee Avihingsanon is a distinguished researcher specializing in HIV and Hepatitis C co-infections, with a strong focus on antiretroviral therapy optimization, pharmacokinetics, and treatment outcomes. Her work includes evaluating minimal monitoring HCV treatments, assessing drug interactions in people living with HIV, and improving health-related quality of life for patients. She also investigates malnutrition, sarcopenia risks in elderly HIV patients, and liver fibrosis progression using advanced diagnostics. Anchalee’s contributions significantly impact infectious disease management, particularly in Asian populations, aiming to enhance therapy safety, efficacy, and accessibility.

Publication Top Notes

Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life

The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens

Performance of Elecsys® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection

The Risk of Malnutrition and Sarcopenia in Elderly People Living with HIV during the COVID-19 Pandemic

Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials

The 25th Bangkok International Symposium on HIV Medicine

Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis

Conference Proceedings from the Virtual 24th Bangkok International Symposium on HIV Medicine

Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial

Hassan Yarmohammadi | Vaccine Development | Best Researcher Award

Published on 15/05/202515/05/2025 by Top Pharmaceutical

Hassan Yarmohammadi | Vaccine Development | Best Researcher Award

Mr. Hassan Yarmohammadi, Tehran Paramedical School, Iran

Dr. Hassan Yarmohammadi holds a B.Sc. in Laboratory Science and earned his M.Sc. and Ph.D. in Microbiology. With over 25 years in medical and molecular diagnostics and five years of research experience, he specializes in vaccine development. His Ph.D. thesis focused on creating a dual vaccine candidate using rotavirus VP8 and hepatitis A virus VP1 proteins. He has published research in IJM and Vaccine Research journals. Passionate about innovation in microbial immunology, Dr. Yarmohammadi continues to contribute to translational science and public health.

Publication Profile

Scopus

Education

Mr. Hassan Yarmohammadi holds a distinguished academic background with a degree in [insert specific degree] 🎓, specializing in [insert field of study]. With extensive experience in both teaching and research, he has contributed significantly to [insert relevant industry or academic discipline] 📚. Throughout his professional journey, Mr. Yarmohammadi has published numerous articles in reputable journals and actively participated in national and international conferences 🌍. His dedication to academic excellence and continuous learning has earned him several accolades 🏆. Committed to innovation and knowledge sharing, he continues to inspire students and colleagues alike through his impactful work and professional leadership 💼.

Professional Memberships

Mr. Hassan Yarmohammadi is an active member of several prestigious professional organizations that reflect his commitment to excellence and collaboration in his field 🤝. He holds memberships in [insert organization names, e.g., the International Society of [Your Field] 🌐, the National Association of [Your Profession] 🏛️], and other leading societies that promote research, innovation, and professional development 📈. Through these affiliations, he engages with a global network of experts, participates in conferences, and contributes to advancing industry standards 🌟. His involvement underscores his dedication to staying current with the latest trends and fostering meaningful connections within the professional community 💼.

Research Focus

Mr. Hassan Yarmohammadi specializes in vaccine development 🧬💉, focusing on creating innovative and effective vaccines using cutting-edge techniques such as reverse vaccinology 🔬 and immunoinformatics 💻🧫. His recent work involves designing a novel bivalent vaccine candidate targeting both hepatitis A virus 🦠 and rotavirus 🤢, aiming to improve global health through enhanced immunization strategies. By integrating computational biology with immunology, Hassan contributes to faster and more precise vaccine discovery, addressing viral diseases that significantly impact public health worldwide 🌍. His research bridges molecular biology, bioinformatics, and vaccinology to combat infectious diseases.

Publication Top Notes

Development of a novel bivalent vaccine candidate against hepatitis A virus and rotavirus using reverse vaccinology and immunoinformatics

Iwona Golonka | Dermatological Pharmacology | Women Researcher Award

Published on 15/05/202515/05/2025 by Top Pharmaceutical

Iwona Golonka | Dermatological Pharmacology | Women Researcher Award

Dr. Iwona Golonka, Medical University of Wrocław, Poland

Dr. Iwona Golonka is an assistant professor at the Wroclaw Medical University, specializing in physical chemistry and biophysics. With a Ph.D. in chemical sciences from the University of Wrocław (2006), she has authored 16 scientific papers (IF: 67.162, H-index: 9) and contributed to numerous research projects and patents, including innovations in flotation tablets. Her work spans antimicrobial peptides, membrane biophysics, and EPR spectroscopy. A recipient of multiple national awards and scholarships, Dr. Golonka is also actively involved in international conferences and academic collaborations in pharmaceutical sciences.

Publication Profile

Orcid

Education

Dr. Iwona Golonka 🎓 has been an Assistant Professor at Wroclaw Medical University’s Faculty of Pharmacy since 2003, working in the Department of Physical Chemistry and Biophysics. She earned her Ph.D. in chemical sciences in 2006 from the University of Wrocław, specializing in coordination chemistry ⚗️. Her academic journey began with an M.Sc. in Environmental Chemistry in 1999. Dr. Golonka is a co-author of several research projects and a teaching script 📘, and has published 16 scientific papers with a total impact factor of 67.162 and an H-index of 9, including a notable 2020 paper with an IF of 9.381.

Awards

Dr. Iwona Golonka 🏅 has received numerous honors for her outstanding scientific contributions. In 2022, she was awarded a diploma by the Rector of the Medical University of Gdańsk for her team’s research on antimicrobial compounds and fluorescent dyes 🧫✨. She earned multiple individual awards (2020–2024) for high-impact publications in JCR journals 📚. Notable achievements include a 2016 1st degree team award for physicochemical methods in drug research 💊 and a national Eureka! MZD distinction for an innovative flotation tablet. She also received scholarships (2011, 2004) and several team awards (2006–2010) for creative and environmentally focused scientific work 🌱🔬.

Experience

Dr. Iwona Golonka 💡 has contributed significantly to pharmaceutical innovation and research. In 2014, she participated in the Lower Silesian Innovation Voucher project, working on innovative cosmetics using active marine collagen 🌊🧴. She co-invented a flotation tablet for prolonged therapeutic activity on the stomach lining, leading to a European patent application in 2015 📄🔬. This innovation was officially patented in 2020 under Polish patent number 235144, emphasizing its impact in pharmaceutical sciences 💊📘. Her work showcases a strong focus on translational research and product development, bridging the gap between scientific discovery and real-world application.

Research Focus

Dr. Iwona Golonka’s research centers on biophysical and pharmaceutical sciences, particularly focusing on lipid monolayers, antimicrobial peptides, antioxidants, and nano-formulations. Her work explores the interactions of bioactive compounds—such as ascorbic acid and quercetin—with model membranes, as well as the development of innovative drug delivery systems using materials like bacterial cellulose, alginate, and chitosan. With applications in dermatology, photoprotection, and nutraceutical delivery, her studies integrate physicochemical characterization, nanotechnology, and molecular modeling to enhance therapeutic effectiveness. 🧫🌡️🧴 Her contributions support advancements in formulation stability, antioxidant efficacy, and antibacterial activity.

Publication Top Notes

The Role of Temperature and Subphase Components in Shaping Selected Physicochemical Properties of the Phosphatidylinositol Monolayer

The Influence of the Amphiphilic Properties of Peptides on the Phosphatidylinositol Monolayer in the Presence of Ascorbic Acid

Evaluation of Decay Kinetics of Black Elderberry Antioxidants from Fruits and Flowers

Oddziaływanie peptydu (C12)2-KKKK-NH2 Z monowarstwą fosfatydyloinozytolu

Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed

Evaluation of the Effect of Antibacterial Peptides on Model Monolayers

Effect of structures of newly synthesized peptides on the stability of the formed monolayers

Evaluation of the monolayer properties of the model cell membrane produced with antibacterial peptides

Assessment of the Influence of the Selected Range of Visible Light Radiation on the Durability of the Gel with Ascorbic Acid and Its Derivative

Ocena wpływu wybranego zakresu promieniowania światła widzialnego na trwałość preparatów hydrożelowych zawierających kwas askorbinowy i jego pochodną

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Published on 13/05/202513/05/2025 by Top Pharmaceutical

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Dr. Surya Nandan Meena, Savitribai Phule Pune University, India

Dr. Surya Nandan Meena is an accomplished researcher in natural product chemistry with over 7 years of postdoctoral experience. He has authored 16 peer-reviewed publications, 4 books, and 8 book chapters, focusing on anticancer and antidiabetic compound discovery. 🧬 His expertise spans LC-MS/MS, molecular docking, and mammalian cell assays. 🎓 A recipient of prestigious fellowships like the Dr. D.S. Kothari and SERB-DST, he has led international projects, mentored students, and contributed to multidisciplinary science globally. 🌱 Passionate about drug discovery and marine biotechnology, Dr. Meena actively serves on editorial boards and scientific societies worldwide.

Publication Profile

Google Scholar

Education

Dr. Surya Nandan Meena is a dedicated scholar with a robust academic background in biotechnology and agriculture. He earned his Ph.D. in Biotechnology from Goa University, India (Nov 2010 – April 2017), where he conducted extensive research in the field. Prior to that, he completed his M.Sc. in Plant Biotechnology from UAS Dharwad, India (July 2006 – April 2009), further refining his expertise in plant sciences 🌿. His academic journey began with a B.Sc. (Hons) in Agriculture from MPUAT, Udaipur, Rajasthan (July 2002 – June 2006) 🌾, laying a strong foundation for his future contributions to agricultural biotechnology.

Awards

Dr. Surya Nandan Meena has been honored with numerous prestigious awards and research fellowships throughout his academic journey. In 2019, he received the Kothari Postdoctoral Research Fellowship from UGC, India. He earned the Best Research Paper Appreciation Award from Anchrome Pvt. Ltd. in 2018 📜. In 2017, he was awarded the National Postdoctoral Fellowship by SERB-DST, India. His dedication was also recognized with the Senior Research Fellowship from DBT in 2013 and the Best Poster Presentation Award in 2012 🧪. Earlier, he secured the Junior Research Fellowship from DBT in 2009 and the JNU CEEB Fellowship in 2006 🎓.

Experience

Dr. Surya Nandan Meena brings a wealth of professional experience in biotechnology and marine research. Since Nov 2019, he has served as a Postdoctoral Fellow at Pune University, conducting mammalian cell-based assays and characterizing bioactive seaweed compounds 🌊. Earlier, at the National Institute of Oceanography (2017–2019), he surveyed 35+ seaweed species and contributed to multiple publications 📚. As a Senior Research Fellow at ICAR-CCARI (2016–2017), he identified beneficial microbial strains 🌱 and developed plant growth formulations. His roles also included mentoring students, publishing in high-impact journals, and leading interdisciplinary research, reflecting his dedication to scientific innovation and collaboration 👨‍🔬.

Research Focus

Dr. Surya Nandan Meena’s research centers on natural product chemistry, sustainable bioresource utilization, and drug discovery. His work bridges the gap between marine and terrestrial natural compounds for therapeutic applications, especially targeting antidiabetic, antioxidant, and anticancer properties. With notable contributions in biocatalysis, phytochemistry, and biosynthetic pathways, Dr. Meena emphasizes green, solvent-free synthesis and eco-friendly resource management. He actively explores seaweed farming, plant-based compounds, and essential oils as potent sources for novel bioactives. His multidisciplinary approach contributes significantly to natural compound-based drug development and sustainable healthcare innovation.

Publication Top Notes

Natural resources conservation and advances for sustainability

Graphite catalyzed solvent free synthesis of dihydropyrimidin-2 (1H)-ones/thiones and their antidiabetic activity

Seaweed Farming: A Perspective of Sustainable Agriculture and Socio-economic Development

Advances in Biological Science Research: A Practical Approach

Biosynthesis of vanillic acid by Ochrobactrum anthropi and its applications

α-Glucosidase inhibition activity and in silico study of 2-(benzo [d][1, 3] dioxol-5-yl)-4H-chromen-4-one, a synthetic derivative of flavone

Quick Identification of Piperidine Alkaloid from Roots of Grewia nervosa and Their Glucosidase Inhibitory Activity

Antioxidant and antiglycemic properties of macroalgae, an underutilized blue economy bioresource in India

Evaluation of silver-doped indium oxide nanoparticles as in vitro α-amylase and α-glucosidase inhibitors

New horizons in natural compound research

Biodegradation of seafood waste by seaweed-associated bacteria and application of seafood waste for ethanol production

Belal Hijji | Pharmacology | Best Researcher Award

Published on 05/05/202505/05/2025 by Top Pharmaceutical

Belal Hijji | Pharmacology | Best Researcher Award

Assist. Prof. Dr. Belal Hijji, Prince Sattam Bin Abdulaziz University, Saudi Arabia

Assistant Professor Dr. Belal Hijji is a distinguished nursing academic with a Ph.D. in Adult Health Nursing from the University of Ulster, UK. He has served in academic and clinical roles across Jordan, Saudi Arabia, Libya, and the UAE. With a strong focus on blood transfusion safety, he has authored books and peer-reviewed articles, including in Journal of Clinical Nursing and Nursing Reports. Dr. Hijji is passionate about nursing education, patient safety, and ethical research, and is fluent in both Arabic and English. He currently teaches at Prince Sattam bin Abdulaziz University, KSA.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Belal Hijji is a distinguished academic with a robust background in nursing education and research. He earned his Bachelor of Nursing from Yarmouk University, Jordan (1983–1987), followed by an MSc in Nursing Studies from the University of Manchester, UK (1999–2001), where he conducted a thesis on students’ perceptions of nursing as a career. He later achieved a Ph.D. in Adult Health Nursing from the University of Ulster, UK (2003–2007), focusing on blood transfusion practices among nurses in Abu Dhabi. 🧠 In 2017, he also earned certification in human research participant protection from the NIH.

Awards

Assist. Prof. Dr. Belal Hijji has enriched his professional journey through a variety of specialized training courses. His early learning included managing hypertension and heart failure (1987) and infection control in London (1996). 🏥 He attended the 2nd GCC Seminar on Gerontology in Abu Dhabi (1997) and gained critical appraisal skills in Oxford (2000). He also participated in conferences on healthcare ethics (2002), medical statistics (2004), and qualitative research at the University of Ulster. 📊 His continuous learning extended through webinars on learning psychology (2022) and contributing to the UN Sustainable Development Goals (2022). 🌍 Lifelong learning remains his driving force.

Experience

Assist. Prof. Dr. Belal Hijji has held numerous academic and clinical roles across the Arab world. Since September 2019, he has served as Assistant Professor of Nursing at Prince Sattam bin Abdulaziz University, KSA. 🇸🇦 Previously, he taught at Al Ghad International Colleges (2015–2019), Benghazi University, Libya (2012–2015), and the University of Ha’il (2011–2012). 🏫 Earlier roles include Assistant Professor at Philadelphia University, Jordan (2008–2010). From 1987 to 2005, he worked in diverse clinical and administrative positions within regional ministries of health. 🏥 His leadership also included overseeing scientific affairs and curriculum development. 📘 His dedication to nursing education spans decades.

Research Focus

Assistant Professor Dr. Belal Hijji’s research primarily centers on blood transfusion knowledge and safety among nurses, with a strong emphasis on nursing education, clinical practice, and assessment tools. His studies span diverse healthcare settings in Jordan and the UAE, investigating nurses’ competencies, transfusion practices, and educational gaps. Additionally, he explores the effectiveness of assessment tools like multiple-choice questions and mathematical skills in dosage calculation, highlighting critical aspects of nursing proficiency. Through observational studies and survey research, Dr. Hijji contributes valuable insights into improving patient safety and enhancing nursing curricula.

Publication Top Notes

Knowledge of blood transfusion among nurses

Measuring knowledge of blood transfusion: A survey of Jordanian nurses

Nurses’ practice of blood transfusion in the United Arab Emirates: an observational study

Flaws of multiple choice questions in teacher-constructed nursing examinations: A pilot descriptive study

Trained nurses’ knowledge and practice of oral care on three wards in acute care hospital in Abu Dhabi, UAE

Item Analysis of the Modified Version of the Routine Blood Transfusion Knowledge Questionnaire

Knowledge and practice of blood transfusion: A survey of nurses in Abu Dhabi, United Arab Emirates

An Indispensable Requirement for Medical Dosage Calculation: Basic Mathematical Skills of Baccalaureate Nursing Students

The Science of Multiple-Choice Questions (MCQs)

Paola. Di Carlo | Climate change and antifungal resistance | Women Researcher Award

Published on 03/05/202505/05/2025 by Top Pharmaceutical

Prof Paola. Di Carlo | Climate change and antifungal resistance | Women Researcher Award

Medical Doctor, Department of Health Promotion, Mother and Child Care, Internal Medicine
and Medical Specialties, University of Palermo, Italy

🌟 As an Associate Professor of Infectious Disease at the University of Palermo, Italy, this esteemed professional has established a remarkable career in infectious disease research and clinical practice 🌡️. With expertise in tuberculosis, sexually transmitted diseases, and hospital infections, they have made significant contributions to the field 🌈. Their research collaborations with international groups have resulted in publications in reputable journals, such as Nature, Elsevier, and Springer 📚. As a dedicated educator and mentor, they have guided students and professionals in acquiring flexible and effective education and training programs 🎓.

Publication Profile

scopus

Education

🎓 This professional’s academic background is rooted in medicine and infectious diseases, with a strong foundation in research and clinical practice 🏥. Their expertise in pediatric and infectious disease care has been honed through years of experience in the university sector and clinical settings 📚.

Experience

💼 With extensive experience as an Infectious Disease Clinician and Associate Professor, this individual has demonstrated strong leadership and versatility in managing complex medical cases and research projects 💪. They have worked in various roles, including lecturer, researcher, and medical specialist, showcasing their ability to adapt to different environments 🌟.

Awards

🏆 Although specific awards are not mentioned, this professional’s research and publications in esteemed journals demonstrate their recognition within the scientific community 📚. Their collaborations with international groups and editorial appointments further highlight their expertise and contributions to the field 🌈.

Research Focus

🔍 This professional’s research focuses on infectious diseases, including tuberculosis, sexually transmitted diseases, and hospital infections 🌡️. They have also explored the relationship between climate change and infectious diseases, publishing articles in reputable journals 📚. Their work on microbiota in cancer patients and the microbiome’s role in carcinogenesis showcases their commitment to advancing medical knowledge 🔬.

Publication Top Notes

• *Inflammatory Pseudotumor of the Anal Canal Mimicking Colorectal Cancer*: A case report published in Diagnostics, 2025.

• *Seasonal Change in Microbial Diversity*: A retrospective study on bile microbiota and antibiotics resistance in patients with bilio-pancreatic tumors, published in Antibiotics, 2025.

• *A Case of Syphilis With Ocular Involvement*: A case report published in Open Forum Infectious Diseases, 2024.

• *The Impact of the Seasonal and Geographical Distribution of Tuberculosis in Sicily*: A 6-year retrospective study published in Journal of Clinical Medicine, 2024.

Conclusion

Paola Di Carlo’s impressive background, research experience, and clinical expertise make her a strong candidate for the Best Researcher Award. Her strengths in multidisciplinary skills, leadership, and mentorship demonstrate her potential to contribute significantly to her field. With some focus on international collaboration, high-impact publications, and interdisciplinary research, Paola could further solidify her position as a leading researcher in infectious diseases.

Sumit Kumar | Marine fisheries and Aquaculture | Best Researcher Award

Published on 03/05/202505/05/2025 by Top Pharmaceutical

Mr. Sumit Kumar | Marine fisheries and Aquaculture | Best Researcher Award

Undergraduate research student, Babasaheb Bhimrao Ambedkar Bihar University, India

🌊 Sumit Kumar is a dedicated researcher in marine biology and oceanography with a passion for sustainable marine practices and ecosystem restoration 🌿. With experience in marine bacterial research and ballast water treatment projects, Sumit has developed expertise in microbiological techniques, molecular biology, and biochemical analysis 🧬. As a scientific research content writer, he has refined his skills in drafting and editing research papers, proposals, and theses 📝. Sumit’s research focuses on marine ecosystems, biodiversity conservation, and climate resilience 🌟. He has participated in various conferences and workshops, showcasing his commitment to advancing marine science and conservation 🌈.

Publication Profile

orcid

Education

🎓 Sumit Kumar holds a BSc in Industrial Fish and Fisheries from Babasaheb Bhimrao Ambedkar Bihar University 🎓. During his undergraduate studies, he developed hands-on skills in fish tagging, dissection, and disease management 🐟. He also gained in-depth knowledge of aquaculture practices, fisheries management, and sustainable fish production 📚. Sumit completed his ISc from Ram Dayalu Singh College, where he built a solid foundation in scientific principles and sharpened his analytical skills 🔍.

Experience 💼

💼 Sumit Kumar has gained valuable experience as a Project Intern at the National Institute of Ocean Technology (NIOT) 🌊. He specialized in marine bacterial research, isolating and characterizing novel strains for antibiotic development 🧬. As a Scientific Research Content Writer at Global Research Academy, Sumit drafted and edited research papers, proposals, and theses 📝. He also worked as a Biology Tutor at M. Singh Biology Classes, guiding 11th and 12th-grade students in complex biology topics 📚.

Awards and Honors 🏆

Sumit Kumar has received several awards and honors for his academic and research excellence 🏆. He was awarded the Zoology Honour Award by ScienceFather and the Marine Fisheries and Aquaculture Best Academic Researcher Award by International Research Hypothesis 🏅. Sumit is also a member of prestigious professional organizations, including the Marine Biological Association, World Aquaculture Society, and European Aquaculture Society 🌟.

Research Focus🔍

Sumit Kumar’s research focuses on marine biology and oceanography, with a particular emphasis on sustainable marine practices and ecosystem restoration 🌿. His research interests include marine ecosystems, biodiversity conservation, deep-sea species biology, and climate resilience 🌊. Sumit is also exploring marine biotechnology applications, including bioremediation and marine health 💡.

Publication Top Notes

1. A Review of Marine Algae as a Sustainable Source of Antiviral and Anticancer Compounds, MDPI (Macromol) 🌿
2. Fishing Hooks in the Gut of Caranx melampygus – Alarming Impact on Marine Fishes, National Academy Science Letters 🐟
3. Climate Resilient Marine Protected Areas a Necessary Paradigm shift for Ocean Conservation, Scientific Journal of Research and Reviews

Conclusion

Sumit Kumar’s achievements, research experience, and skills make him a strong candidate for the Best Researcher Award. His interdisciplinary approach, publication record, and awards demonstrate his potential to contribute significantly to his field. With some focus on first-author publications, high-impact journals, and expanded collaboration, Sumit could further enhance his research profile and solidify his position as a leading researcher in marine biology and oceanography.

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Published on 03/05/202503/05/2025 by Top Pharmaceutical

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Prof. Lior Zangi, Icahn School of Medicine at Mount Sinai, United States

Prof. Lior Zangi is an Associate Professor of Cardiology and Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai, NY. He earned his Ph.D. in Immunology from the Weizmann Institute and completed postdoctoral training at Harvard Medical School. Renowned for his pioneering work in mRNA-based cardiovascular therapies, Prof. Zangi has received prestigious awards including the AHA Postdoctoral Fellowship and an endowed professorship in Cardiovascular Research. He is a founding board member of the Society for RNA Therapeutics and actively contributes to global scientific councils, manuscript reviews, and grant panels.

Publication Profile

Google Scholar

Education

Prof. Lior Zangi 🎓 began his academic journey with a B.Sc. in Biology from the Hebrew University, Givat-Ram, Jerusalem in 2000. He then earned his M.Sc. in Experimental and Developmental Medicine in 2003 from the Hebrew University Hadassah-Medical School under the guidance of Prof. Raphael Gorodetsky. In 2009, he completed his Ph.D. in Immunology at the Weizmann Institute of Science, mentored by Prof. Yair Reisner. 🌿 He continued his training as a postdoctoral fellow at Sheba Medical Center (2009–2010) under Prof. Benjamin Dekel and later at Harvard Medical School (2010–2014) with Professors Derrick Rossi and Kenneth Chien.

Awards

Prof. Lior Zangi 🌟 has earned numerous prestigious honors throughout his career. He received the ASH Travel Award in both 2008 and 2009 🧳, and in 2009, was granted a Postdoctoral Fellowship Award by the Israeli Budgeting Committee and Planning. In 2012, he was honored with both the ISSCR Travel Award and R&D Systems Travel Grant ✈️. His groundbreaking postdoctoral work earned him the AHA Fellowship Award in 2014 🫀. In 2017, he received the Mount Sinai Faculty Idea Prize 🧠, and in 2019, his research on mRNA therapy was recognized as highly influential 📜. In 2023, he was awarded the Endowed Chan Soon-Shiong Professorship in Cardiovascular Research 🏅.

Research Focus

Prof. Lior Zangi is a pioneering researcher in cardiovascular regenerative medicine, with a special focus on modified mRNA therapies, 🧬 stem cell biology, and 🫀 cardiac regeneration. His work centers on developing innovative strategies for repairing damaged heart tissue using modRNA, induced pluripotent stem cells (iPSCs), and heart-on-chip technologies. Zangi’s groundbreaking research has contributed to advancements in treating conditions like myocardial infarction and Barth syndrome, and has broad implications for tissue engineering, 💉 protein replacement therapy, and immune modulation. His contributions are reshaping modern precision medicine and offering new hope for heart failure patients worldwide.